What can we help you with today?
Filter by Topics
Filter by Category
Found 1008 results
Workspan Daily
09/04/2025
;
;The Impact of the H.R. 1 Law on the Telehealth Safe Harbor;
Access additional Workspan Daily Plus+ articles related to H.R 1:
;Checklist for Total Rewards to Be Compliant with H.R. 1 Provisions;
;The Ripple Effect: 529 Plans as a Catalyst for Financial Stability;What Are TR Pros’ Options for Paid Care Leave Design;
Growing Care Needs
The federal income tax credit for employers offering PFML was first introduced with passage of the 2017 Tax Cuts and Jobs Act.
Author(s):
Workspan Daily
08/26/2024
One cost driver is the expanded use of glucagon-like peptide 1 (GLP-1) drugs, which primarily fight diabetes but recently have been prescribed to treat several “off label” conditions.
Author(s):
Workspan Magazine
12/03/2025
Most large employers are requiring an ROI of at least 2:1 or 3:1 for each health management program offering.
Author(s):
Workspan Daily
10/13/2025
That figure for 2026, which considers the financial impact if employers took no action to lower their costs, is in line with other industry prognostications, including:
;Business Group on Health (9%);
;Mercer (9%);
WTW survey respondents identified three primary cost drivers for the year ahead:
;Pharmaceuticals , primarily specialty drugs and
glucagon-like peptide-1 (GLP-1) medications;;
;High-cost claimants; and,;
;Chronic conditions, especially musculoskeletal disorders and cancers.;
As a result of rising costs, claimants and conditions, 1 in 3 surveyed leaders anticipate making “significant changes” to their healthcare benefit programs within the next three years.
Author(s):
Workspan Daily
08/10/2023
After its costs for the drugs more than tripled over the past 18 months to about $5 million a month, the University of Texas System said it would end insurance coverage of Novo Nordisk’s Wegovy and Saxenda for its employees and others covered by its health plans effective Sept. 1, according to the Wall Street Journal .
Author(s):
Workspan Daily Plus+
11/06/2025
.,
glucagon-like peptide-1 [GLP-1] agonists, calcitonin gene-related peptide [CGRP] inhibitors) on the formulary, or are there financial hurdles?
Author(s):
Workspan Daily
08/19/2025
For WorldatWork Members Total Rewards Inventory of Programs & Practices , research;Health Insurance Selection Checklist for Employees , Workspan Daily Plus+ article;What Does the Data Show on GLP-1 Prescribe Rates, Coverage, Costs?
Author(s):
Workspan Daily
08/04/2021
Employers can require timely aggregate reporting from every vendor, which should include care delivered and handoffs or interactions with other providers or vendors.
Author(s):
Workspan Daily
06/12/2024
PVP Year 2 Disclosures Show Consistency with Year 1 WTW research found that the overall trends in PVP disclosures were comparable to those in the first year of PVP in 2023 (see Figure 1).
Author(s):
Workspan Daily Plus+
03/03/2025
Even if the employer has not yet implemented nudge technology in their workplace, their third-party administrators, health insurance providers, wellness vendors and other vendors are likely using it, challenging total rewards professionals to stay ahead of the compliance issues and be aware of the potential negative impact on workplace culture.
Author(s):